BPC
TMDX icon

Bryce Point Capital’s Transmedics TMDX Stock Holding History

Bryce Point Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$688K Buy
+6,131
New +$718K 0.84% 4

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bryce Point Capital's TMDX Position: Q3 2025 in Review

Bryce Point Capital opened a new position in Transmedics (TMDX) in Q3 2025: 6,131 shares worth $688K. The stake represents 0.84% of the portfolio and ranks #4 among its holdings.

388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • Bryce Point Capital held 6,131 shares of Transmedics worth $688K as of Q3 2025.
  • Transmedics was a new Bryce Point Capital position in Q3 2025.
  • Transmedics made up 0.84% of Bryce Point Capital's portfolio in Q3 2025, its #4 holding.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.